Entera Bio Stock Market Value
| ENTX Stock | USD 1.46 0.01 0.68% |
| Symbol | Entera |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. Projected growth potential of Entera fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Entera Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Entera Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Entera Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Entera Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Entera Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Entera Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Entera Bio.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Entera Bio on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Entera Bio or generate 0.0% return on investment in Entera Bio over 90 days. Entera Bio is related to or competes with Anixa Biosciences, VistaGen Therapeutics, Opus Genetics, Seer, TuHURA Biosciences, Acumen Pharmaceuticals, and Seres Therapeutics. Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally ... More
Entera Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Entera Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Entera Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 22.41 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 8.57 |
Entera Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Entera Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Entera Bio's standard deviation. In reality, there are many statistical measures that can use Entera Bio historical prices to predict the future Entera Bio's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.36) | |||
| Treynor Ratio | (3.54) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entera Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Entera Bio January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | (3.53) | |||
| Mean Deviation | 3.48 | |||
| Coefficient Of Variation | (457.03) | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.66 | |||
| Information Ratio | (0.23) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.36) | |||
| Treynor Ratio | (3.54) | |||
| Maximum Drawdown | 22.41 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 8.57 | |||
| Skewness | 0.5799 | |||
| Kurtosis | 0.8132 |
Entera Bio Backtested Returns
Entera Bio secures Sharpe Ratio (or Efficiency) of -0.22, which denotes the company had a -0.22 % return per unit of risk over the last 3 months. Entera Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Entera Bio's Variance of 21.66, standard deviation of 4.65, and Mean Deviation of 3.48 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.29, which means not very significant fluctuations relative to the market. As returns on the market increase, Entera Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Entera Bio is expected to be smaller as well. At this point, Entera Bio has a negative expected return of -1.02%. Please make sure to confirm Entera Bio's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if Entera Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.74 |
Good predictability
Entera Bio has good predictability. Overlapping area represents the amount of predictability between Entera Bio time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Entera Bio price movement. The serial correlation of 0.74 indicates that around 74.0% of current Entera Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Additional Tools for Entera Stock Analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.